Rhenman & Partners Asset Management AB Has $13.40 Million Position in Cigna Group $CI

Rhenman & Partners Asset Management AB increased its stake in Cigna Group (NYSE:CI) by 45.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 46,500 shares of the health services provider’s stock after acquiring an additional 14,500 shares during the period. Cigna Group comprises 1.5% of Rhenman & Partners Asset Management AB’s investment portfolio, making the stock its 28th biggest position. Rhenman & Partners Asset Management AB’s holdings in Cigna Group were worth $13,404,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Pathway Financial Advisers LLC raised its holdings in Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after purchasing an additional 34 shares during the period. Armstrong Advisory Group Inc. grew its holdings in shares of Cigna Group by 17.7% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after buying an additional 34 shares during the period. HM Payson & Co. increased its position in shares of Cigna Group by 0.9% in the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock valued at $1,091,000 after buying an additional 35 shares in the last quarter. Carr Financial Group Corp increased its position in shares of Cigna Group by 5.3% in the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after buying an additional 36 shares in the last quarter. Finally, Natural Investments LLC raised its stake in Cigna Group by 2.0% during the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock worth $531,000 after buying an additional 36 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CI. Mizuho set a $325.00 target price on Cigna Group in a research note on Friday, January 9th. TD Cowen raised their price target on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Barclays cut their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. Deutsche Bank Aktiengesellschaft increased their target price on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Finally, Robert W. Baird reduced their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $330.42.

Cigna Group Trading Down 3.5%

NYSE CI opened at $271.50 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The stock’s 50 day moving average price is $280.71 and its two-hundred day moving average price is $284.11. The stock has a market capitalization of $71.55 billion, a price-to-earnings ratio of 12.24, a PEG ratio of 0.94 and a beta of 0.27.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the business earned $6.64 EPS. The business’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date is Thursday, March 5th. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.